Image Credit: Canva
When was the last time you measured your waistline? If you assume that BMI is the only number to focus on when it comes to your health, think twice. New research has revealed a shocking revelation—your waist circumference might be a far better predictor of men's cancer risk than BMI.
The study finds that for each 4-inch increase in waist size, a man's risk of cancer increases by a staggering 25%. Meanwhile, BMI, commonly regarded as the gold standard for assessing obesity, raises cancer risk by only 19% for the same weight gain. So, if you've been dismissing that pesky belly fat, it's time to take notice.
But why is your waistline so important? The reason is visceral fat—the hidden, deep fat that accumulates around your organs. Unlike other body fat, visceral fat is a stealthy troublemaker, causing inflammation, insulin resistance, and abnormal blood fat levels—all of which combine to create a cancer-perfect storm.
Obesity has been associated with an increased risk of numerous health conditions, including cancer, for decades. The research, though, indicates that a specific measure of the body—waist circumference—may be an even more reliable forecaster of cancer risk in men than the more frequently employed Body Mass Index (BMI). This finding emphasizes the need to pay particular attention to the distribution of fat and not merely to the weight of the body.
BMI has been the go-to measure for years for gauging health risks related to obesity. New research, though, that appears in The Journal of the National Cancer Institute indicates that waist measurement is a better predictor of cancer risk in men. According to the research, four more inches (10 cm) around the waist will add 25% to a man's cancer risk. Conversely, a 3.7 kg/m² rise in BMI (from a BMI of 24 to 27.7) increased cancer risk by only 19%.
Why is waist circumference a better predictor, then? Unlike BMI, which measures weight relative to height, waist circumference actually measures abdominal fat—specifically, visceral fat. This type of fat encircles internal organs and is also linked to higher levels of inflammation, insulin resistance, and abnormal blood lipids, all of which are factors in cancer growth. BMI, however, does not measure fat distribution, so two individuals with the same BMI can have very different levels of health risk depending on where fat is deposited on their bodies.
Interestingly, the research identified a significant difference between men and women when it came to waist circumference and cancer risk. Although waist circumference and BMI were linked with obesity-related cancers in women, the relationship was weaker than for men. An increase of 12 cm (4.7 inches) in waist size or a 4.3 rise in BMI (from 24 to 28.3) raised the cancer risk in women by just 13%—a much lower percentage than for men.
Experts credit this difference to the way that fat is stored in the body. Men are more likely to carry fat around the abdomen, especially as visceral fat, which is more metabolically active and associated with cancer-producing biological alterations. Women, by contrast, store fat in peripheral sites such as the hips and thighs, where it is less likely to drive systemic inflammation and metabolic disturbances.
A possible reason is that men tend to depot fat more in the visceral regions, whereas women tend to carry more subcutaneous and peripheral fat," wrote the researchers. "This may render waist circumference a more robust risk factor for cancer in men and account for why waist circumference provides additional risk information beyond BMI in men but not women."
The research used the International Agency for Research on Cancer (IARC) data to define obesity-related cancers. These cancers are esophageal (adenocarcinoma), gastric (cardia), colorectal, rectal, liver, gallbladder, pancreatic, renal, and thyroid cancers, and multiple myeloma and meningioma. In men, abdominal obesity is especially significant in raising the risk of these cancers through high levels of insulin and markers of inflammation.
For women, the research proposes that both waist circumference and hip circumference may give a more accurate estimate of visceral fat and cancer risk. "Adding hip circumference to risk models could strengthen the link between waist circumference and cancer, especially in women," researchers observed.
With these results, doctors advise men to be more mindful of their waistline than only their BMI. Waist size is an easy method to gauge health risk, and its maintenance through lifestyle changes might be the key to cancer prevention.
Track Your Waist Size: Regularly measure your waist circumference and try to keep it in a healthy range (below 40 inches for men, according to medical advice).
Eat a Balanced Diet: A diet containing high fiber, lean protein, and healthy fats can assist in limiting visceral fat gain.
Exercise Consistently: Regular exercise with a combination of aerobic and strength training will help maintain a healthy waistline.
Control Stress and Sleep: Persistent stress and inadequate sleep tend to cause weight gain, especially in the midsection of the body.
Regular Health Screenings: Early identification of cancer risk factors through regular screening can greatly enhance long-term health status.
(Credit-Canva)
Pancreatic cancer is widely known as a "silent killer" because it doesn't usually cause pain or noticeable issues until it is very advanced and hard to treat. This is why doctors and researchers are always searching for earlier signs. Fortunately, new research has uncovered a possible warning sign that could help find the disease much sooner. Detecting this cancer early, when it is small and hasn't spread, gives patients the best chance for a successful recovery.
The statistics for pancreatic cancer show just how deadly it is. Even though it makes up a small percentage of all cancer cases (around 3%), it is responsible for a large number of cancer deaths (about 8%).
This high death rate happens because the cancer is often only found after it has already spread to other organs in the body. When cancer is found late, the chance of survival is very low—only about 3% to 16% of people live for five years or more. Because of these low survival rates, finding a dependable way to spot this cancer early is absolutely essential to saving more lives.
Researchers at Johns Hopkins University School of Medicine have discovered a promising sign that might point to early cancer: the pancreatic duct is enlarged. The pancreatic duct is basically a tube that carries the digestive juices out of the pancreas.
In their study, published in the journal Gastro Hep Advances, the research team found that if this duct is swollen or enlarged, it suggests a much higher risk of developing pancreatic cancer. This sign is particularly important for people who already have a high chance of getting the disease due to family history or genetics.
The researchers studied 641 people who were already considered to be at a high risk for pancreatic cancer, either because close family members (like parents or siblings) had it, or because they had specific genes that increase the danger.
Key Discovery: They found that 97 of these high-risk patients had this enlarged pancreatic duct.
Increased Odds: When they tracked these patients, they found that those with the duct enlargement were 2.6 times more likely to eventually get pancreatic cancer compared to the people without the enlargement. The danger was even greater if they had the enlarged duct and three or more fluid-filled sacs, called cysts, on their pancreas.
This discovery gives doctors a clear signal to take action. If a doctor sees an enlarged pancreatic duct on a medical scan—even if the scan was initially ordered for a different issue, like checking for kidney stones or general belly pain—they should immediately treat it as a warning sign.
The action taken would be to either perform very frequent and detailed imaging (scans) to watch the area closely, or in some cases, do surgery to remove the tissue concerned.
Dr. Canto pointed out that sometimes, the swelling in the duct is visible even before the cancerous mass itself is big enough to be clearly seen on a scan. This means doctors have a valuable new chance to step in earlier than ever before.
The research is not stopping here; the team’s next big project is to teach Artificial Intelligence (AI) how to look at pancreas scans. The goal is for the AI to analyze the images and make even more specific and accurate predictions about a person's risk of developing pancreatic cancer.
Credits: Canva
Most toothpaste commercials show a long, dramatic swirl covering the entire length of the toothbrush. But dentists say this is not only misleading, it could actually be harmful.
A video shared by Dr. Miles Madison, Beverly Hills Periodontist & Dental Implant Specialist, has sparked fresh debate on how much toothpaste is truly safe. Paired with expert insights and existing dental research, one message is clear: more toothpaste does not mean better cleaning.
According to Dr. Madison, almost 40% of people use an excessive amount of toothpaste, as shown by CDC findings. The amount typically seen in commercials? “That much is a hell no,” he says.
His guidance on the correct amount is straightforward:
Use only a smear, roughly the size of a grain of rice.
This tiny amount protects the teeth without overexposing children to fluoride, especially since young kids often swallow toothpaste instead of spitting it out.
Use a pea-sized amount no more.
This is enough to clean the teeth thoroughly without increasing health risks.
Children under eight have teeth and gums that are still developing. Overusing toothpaste, particularly fluoride-containing toothpaste, can trigger dental fluorosis, a condition caused by excess fluoride intake. This results in yellow or white spots, enamel damage, pits, and an increased risk of cavities.
Because children tend to swallow toothpaste, larger amounts can quickly push them into unsafe fluoride levels.
Even though adults are less likely to swallow toothpaste, using too much can still:
Dentists also warn that people often rely too heavily on toothpaste while neglecting brushing technique — gentle circular motions, not force, and flossing.
However, its benefits peak at a pea-size amount. Beyond that, the risks outweigh the rewards.
Used correctly, toothpaste prevents cavities, gum disease, and tooth loss, but used excessively, it can do more harm than good.

(Credit-Canva)
Highlighting the importance of getting screened, surgeon Christine Lai reveals a key stage of breast cancer that most people do not know about.
Breast cancer is one of the leading cancer diagnoses for women throughout the world. But it is also a highly treatable type of cancer if found early. While most of us know that breast cancer symptoms like lumps in the breast or discharge from the nipples, these symptoms come when the cancer is already progressing to an advanced stage.
The University of Kansas Cancer Center explains that there could be a palpable lump or tenderness, but generally breast cancer has no symptoms in the early stage. But is this stage 1, or stage 2? Which early stage cannot be accurately diagnosed with self-examination.
In a recent post, Dr Christine Lai, Specialist Surgeon based in Australia, details the key stage people do not know about and its not 1 or 2, its stage 0.
Dr Lai explains that stage 0 is the very first and most treatable stage of breast cancer. At this point, no actual lump has formed, and the person usually has no symptoms.
The cancer cells are only sitting inside the milk ducts, where they are growing but have not yet developed the ability to break out and spread into the surrounding breast tissue.
This specific type of cancer is often called Ductal Carcinoma In Situ (DCIS). If we find cancer at this stage, it is almost certainly curable. This is why getting a routine screening mammogram is so crucial—it can catch this hidden stage and save a life.
In the video, Dr Lai details how big the tumor is during each stage, and how is it different from the previous stage, along with their treatability.
Stage 1 cancer means the tumor is quite small and is mostly confined to the breast. The tumor is usually 2 cm or less in size, which is smaller than a cherry. At this point, the cancer either hasn't spread to the lymph nodes at all, or the spread is extremely minimal and only visible under a microscope. Because the cancer is so small and localized, Stage 1 is highly treatable.
Stage 2 means the cancer is either moderately sized or has started to involve a few nearby lymph nodes. This stage applies if the tumor is smaller than 5 cm but has spread to up to three lymph nodes. It also applies if the tumor is larger than 5 cm but hasn't yet spread to any lymph nodes at all. Think of this as the cancer becoming more established, either by growing larger in one spot or starting to spread slightly to the closest glands.
Stage 3 indicates that the cancer has become more aggressive locally, involving more lymph nodes or invading nearby tissues. This applies if there are more than three involved lymph nodes, or if the tumor is invading the chest wall or the skin of the breast. A special type of cancer called inflammatory breast cancer is also classified as Stage 3 because of how it spreads across the breast tissue. This stage requires more intensive treatment because the disease has spread more extensively in the chest area.
Stage 4 is when the breast cancer has spread from the breast and armpit to distant parts of the body, such as the bones, lungs, liver, or brain. This is also known as metastatic breast cancer. While this stage is generally not curable, it is still highly treatable. Treatment focuses on controlling the cancer, relieving symptoms, and allowing the patient to maintain the best possible quality of life.
© 2024 Bennett, Coleman & Company Limited